- SKYE Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
-
Institutional
- Shorts
Skye Bioscience (SKYE) Institutional ownership
Company Profile
Type | Filer | #Shares | Filed | For date | #Previous | %Chg | Prev. Date |
---|---|---|---|---|---|---|---|
13F-HR/A
|
Barclays | 57.40 k | 19 Nov 24 | 30 Sep 24 | 42.34 k | +36% | 30 Jun 24 |
13F-HR
|
Barclays | 57.40 k | 15 Nov 24 | 30 Sep 24 | 42.34 k | +36% | 30 Jun 24 |
13F-HR
|
Jane Street | 7.79 k | 14 Nov 24 | 30 Sep 24 | 0.00 | +∞% | 30 Jun 24 |
13F-HR
|
Point72 Asia | 27.77 k | 14 Nov 24 | 30 Sep 24 | 27.77 k | 0% | 30 Jun 24 |
13F-HR
|
Point72 (DIFC) | 7.87 k | 14 Nov 24 | 30 Sep 24 | 6.00 k | +31% | 30 Jun 24 |
13F-HR
|
Point72 Asset Management | 416.42 k | 14 Nov 24 | 30 Sep 24 | 560.00 k | -26% | 30 Jun 24 |
13F-HR
|
Cubist Systematic Strategies | 6.42 k | 14 Nov 24 | 30 Sep 24 | 3.76 k | +71% | 30 Jun 24 |
13F-HR
|
Schonfeld Strategic Advisors | 959.10 k | 14 Nov 24 | 30 Sep 24 | 431.36 k | +122% | 30 Jun 24 |
13F-HR
|
5AM Venture Management | 9.91 mm | 14 Nov 24 | 30 Sep 24 | 10.18 mm | -3% | 30 Jun 24 |
13F-HR
|
Alyeska Investment | 554.18 k | 14 Nov 24 | 30 Sep 24 | 300.00 k | +85% | 30 Jun 24 |
This data is updated daily from 13F, 13D and 13G SEC filings.
Faded values represent incomplete data for the quarter, where values have been used from the previous quarter for institutions that haven't filed updated data yet.
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.